Thoracic Outlet Syndrome Market Research Report- Forecast to 2027

Thoracic Outlet Syndrome Market Research Report Information: By Type (Neurogenic, Venous, Arterial Thoracic Outlet Syndrome) Diagnosis (Ct Scan, Mri Scan, Blood Tests, Arteriogram), Treatment (Surgery, Medication), End-User – Global Forecast Till 2027

ID: MRFR/MED/4100-HCR | February 2021 | Region: Global | 85 pages

Please note that the assessment period of report has been updated from 2018-2025 to 2020-2027. Cordially fill the sample form for updated data

Market Scenario

Thoracic outlet syndrome is a group of heterogeneous and disabling upper-extremity disorders that occur due to extrinsic compression of neurovascular structures between the clavicle and the first rib. There are three distinct types of thoracic outlet syndrome viz. neurogenic thoracic outlet syndrome, venous thoracic outlet syndrome, and arterial thoracic outlet syndrome. Neurogenic thoracic outlet syndrome is most common, i.e., it constitutes around 85%-90% of thoracic outlet syndrome cases. Venous thoracic outlet syndrome constitutes around 10%-15% of thoracic outlet syndrome cases, whereas arterial thoracic outlet syndrome is found in 2%-5% of thoracic outlet syndrome cases.


Rising cases of trauma and car accidents are boosting the growth of the thoracic outlet syndrome market. Chest injury is one of the causes of thoracic outlet syndrome, and this comes about as a result of traffic accidents in which the collarbone is broken, and the upper ribs are injured. As per the World Health Organization (WHO) report, nearly 20-50 million people incur non-fatal injuries as a result of road traffic accidents.


Other factors such as increasing cases of anatomical defects, high unmet needs of current treatment, and surge in the research and development expenditure, improvement in reimbursement policies are also expected to drive the growth of the market. According to a study published in the Current Issues in Pharmacy and Medical Sciences - De Gruyter journal in 2015, it is found that bone abnormality may be a potential cause of thoracic outlet syndrome. The most common bone abnormalities include irregularities of the clavicle (20%), the cervical rib (70% of cases), and in the different structures of the first rib (10%).


Despite these drivers, there are some issues associated with thoracic outlet syndrome market. Lack of infrastructure in the middle and low-income countries and side effects associated with the drugs may hamper the growth of the market.


It is estimated that thoracic outlet syndrome market is expected to grow at a CAGR 7.0% during the forecast period of 2017-2023.


Research Methodology


 Thoracic Outlet Syndrome


Sources: Annual reports, Press release, White paper, and Company presentation


Intended Audience



  • Hospitals

  • Diagnostic Clinics

  • Research and Development (R&D) Companies

  • Government Research Institute

  • Academic Institutes and Universities


Segmentation


The thoracic outlet syndrome market is segmented on the basis of type, diagnosis, treatment, and end-user.


On the basis of type, the market is segmented into neurogenic thoracic outlet syndrome, venous thoracic outlet syndrome, and arterial thoracic outlet syndrome.


On the basis of diagnosis, the market is segmented into nerve conduction studies, vascular studies, chest X-ray, cervical spine X-rays, computed tomography (CT) scan, magnetic resonance imaging (MRI), and magnetic resonance imaging with angiography (MRA), arteriogram/venogram, and blood tests.


On the basis of treatment, the market is segmented into surgery, medications, physical therapy, and others. The medications segment is further classified into muscle relaxant, thrombolytic medications, anticoagulant medications, and others.


On the basis of end-user, the market is segmented into hospital & Clinics, diagnostic centers, academic and research institutes, drug pharmacies, and others.


Regional Analysis


The Americas dominate the thoracic outlet syndrome market owing to the rising awareness among people, and increasing healthcare expenditure. As per the facts suggested by the Centers for Disease Control and Prevention (CDC), out of the total annual healthcare expenditure, 86% is for people with chronic health conditions in the United States.


Europe holds the second position in the thoracic outlet syndrome market. It is expected that the support provided by government bodies for research & development and improvement in reimbursement policies in healthcare will drive the market in Europe.


Asia Pacific is the fastest growing in thoracic outlet syndrome market, owing to a huge patient pool, developing healthcare technology, and rising healthcare expenditure in some countries within this region. According to the Australian Institute of Health and Welfare, in the years 2015 to 2016, the total health expenditure was USD 170.4 billion, which is 3.6% higher than the expenditure of 2014–15.


The Middle East & Africa has the lowest market for thoracic outlet syndrome due to lack of technical knowledge and poor medical facilities.


Key Players


Some of key the players in the market are Abbott Laboratories, Bayer AG, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Endo Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Mallinckrodt plc., Orient Pharma Co., Ltd., Par Sterile Products, LLC., Sanofi, SteriMax Inc., Upsher Smith Laboratories, Inc., Vertical Pharmaceuticals LLC, and others.



Frequently Asked Questions (FAQ) :


Thoracic outlet syndrome market CAGR would be 7% during the forecast period.

North America would dominate the thoracic outlet syndrome market.

The treatment types discussed in the thoracic outlet syndrome market report are medications, physical therapy, surgery, and others.

Europe is the second-largest thoracic outlet syndrome market region.

The players discussed in the thoracic outlet syndrome market are Bayer AG, Boehringer Ingelheim, Bristol-Myers Squibb, Abbott Laboratories, Upsher Smith Laboratories, Inc., Endo Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Daiichi Sankyo, Orient Pharma Co., Ltd., Par Sterile Products, LLC., Mallinckrodt plc., SteriMax Inc., Sanofi, Vertical Pharmaceuticals LLC, and others.

Table Of Contents:


Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Thoracic Outlet Syndrome Market, By Type

6.1 Introduction

6.2 Neurogenic Thoracic Outlet Syndrome

6.2.1 Market Estimates & Forecast, 2020 – 2027

6.3 Venous Thoracic Outlet Syndrome

6.3.1 Market Estimates & Forecast, 2020 – 2027

6.4 Arterial Thoracic Outlet Syndrome

6.4.1 Market Estimates & Forecast, 2020 – 2027

Chapter 7. Global Thoracic Outlet Syndrome Market, By Diagnosis

7.1 Introduction

7.2 Nerve Conduction Studies

7.2.1 Market Estimates & Forecast, 2020 – 2027

7.3 Vascular Studies

7.3.1 Market Estimates & Forecast, 2020 – 2027

7.4 Chest X-Ray

7.4.1 Market Estimates & Forecast, 2020 – 2027

7.5 Computed Tomography (CT) Scan

7.5.1 Market Estimates & Forecast, 2020 – 2027

7.6 Magnetic Resonance Imaging (MRI)

7.6.1 Market Estimates & Forecast, 2020 – 2027

7.7 Magnetic Resonance Imaging With Angiography (MRA)

7.7.1 Market Estimates & Forecast, 2020 – 2027

7.8 Arteriogram/Venogram

7.8.1 Market Estimates & Forecast, 2020 – 2027

7.9 Blood Tests

7.9.1 Market Estimates & Forecast, 2020 – 2027 Chapter 8. Global Thoracic Outlet Syndrome Market, By Treatment

8.1 Introduction

8.2 Surgery

8.2.1 Market Estimates & Forecast, 2018 – 2023

8.3 Medications

8.3.1 Market Estimates & Forecast, 2018 – 2023

8.4 Physical Therapy

8.4.1 Market Estimates & Forecast, 2018 – 2023

8.5 Others

8.5.1 Market Estimates & Forecast, 2018 – 2023 Chapter 9. Global Thoracic Outlet Syndrome Market, By End User

9.1 Introduction

9.2 Hospital & Clinics

9.2.1 Market Estimates & Forecast, 2020 – 2027

9.3 Diagnostic Centers

9.3.2 Market Estimates & Forecast, 2020 – 2027

9.4 Academic And Research Institutes

9.4.1 Market Estimates & Forecast, 2020 – 2027

9.5 Others

9.5.2 Market Estimates & Forecast, 2020 – 2027

Chapter 10. Global Thoracic Outlet Syndrome Market, By Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 U.S.

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 U.K

10.3.1.6 Rest Of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic Of Korea

10.4.6 Rest Of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest Of The Middle East & Africa

Chapter 10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

Chapter 11 Company Profiles

11.1 Abbott Laboratories

11.1.1 Company Overview

11.1.2 Types Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 Bayer AG

11.2.1 Company Overview

11.2.2 Types Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Boehringer Ingelheim

11.3.1 Company Overview

11.3.2 Types Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Johnson & Johnson Services, Inc.

11.4.1 Company Overview

11.4.2 Types/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Sanofi

11.5.1 Company Overview

11.5.2 Types Overview

11.5.3 Financial Overview

11.5.4 Key Developments

11.6 Vertical Pharmaceuticals LLC

11.6.1 Company Overview

11.6.2 Types Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.7 DAIICHI SANKYO

11.7.1 Overview

11.7.2 Types Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs Of The Market

12.2 Key Companies To Watch

12.3 Prediction Of Thoracic Outlet Syndrome Industry

Chapter 13 Appendix LIST OF TABLES

Table 1 Thoracic Outlet Syndrome Industry Synopsis, 2020 – 2027

Table 2 Thoracic Outlet Syndrome Market Estimates And Forecast, 2020 – 2027, (USD Million)

Table 3 Thoracic Outlet Syndrome Market By Region, 2020 – 2027, (USD Million)

Table 4 Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)

Table 5 Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

Table 6 Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)

Table 7 Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)

Table 8 North America Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)

Table 9 North America Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

Table 10 North America Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)

Table 11 North America Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)

Table 12 US Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)

Table 13 US Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

Table 14 US Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)

Table 15 US Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)

Table 16 Canada Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)

Table 17 Canada Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

Table 18 Canada Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)

Table 19 Canada Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)

Table 20 South America Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)

Table 21 South America Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

Table 22 South America Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)

Table 23 South America Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)

Table 24 Europe Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)

Table 25 Europe Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

Table 26 Europe Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)

Table 27 Europe Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)

Table 28 Western Europe Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)

Table 29 Western Europe Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

Table 30 Western Europe Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)

Table 31 Western Europe Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)

Table 32 Eastern Europe Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)

Table 33 Eastern Europe Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

Table 34 Eastern Europe Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)

Table 35 Eastern Europe Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)

Table 36 Asia Pacific Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)

Table 37 Asia Pacific Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

Table 38 Asia Pacific Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)

Table 39 Asia Pacific Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)

Table 40 Middle East & Africa Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)

Table 41 Middle East & Africa Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)

Table 42 Middle East & Africa Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)

Table 43 Middle East & Africa Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)

LIST OF FIGURES Figure 1 Research Process

Figure 2 Segmentation For Thoracic Outlet Syndrome Market

Figure 3 Segmentation Market Dynamics For Thoracic Outlet Syndrome Market

Figure 4 Global Thoracic Outlet Syndrome Market Share, By Type 2020

Figure 5 Global Thoracic Outlet Syndrome Market Share, By Diagnosis 2020

Figure 6 Global Thoracic Outlet Syndrome Market Share, By Treatment 2020

Figure 7 Global Thoracic Outlet Syndrome Market Share, By End Users, 2020

Figure 8 Global Thoracic Outlet Syndrome Market Share, By Region, 2020

Figure 9 North America Thoracic Outlet Syndrome Market Share, By Country, 2020

Figure 10 Europe Thoracic Outlet Syndrome Market Share, By Country, 2020

Figure 11 Asia Pacific Thoracic Outlet Syndrome Market Share, By Country, 2020

Figure 12 Middle East & Africa Thoracic Outlet Syndrome Market Share, By Country, 2020

Figure 13 Global Thoracic Outlet Syndrome Market: Company Share Analysis, 2020 (%)

Figure 14 Abbott Laboratories: Key Financials

Figure 15 Abbott Laboratories Segmental Revenue

Figure 16 Abbott Laboratories: Geographical Revenue

Figure 17 Bayer AG: Key Financials

Figure 18 Bayer AG: Segmental Revenue

Figure 19 Bayer AG: Geographical Revenue

Figure 20 Boehringer Ingelheim: Key Financials

Figure 21 Boehringer Ingelheim: Segmental Revenue

Figure 22 Boehringer Ingelheim: Geographical Revenue

Figure 23 Johnson & Johnson Services, Inc.: Key Financials

Figure 24 Johnson & Johnson Services, Inc.: Segmental Revenue

Figure 25 Johnson & Johnson Services, Inc.: Geographical Revenue

Figure 26 Sanofi: Key Financials

Figure 27 Sanofi: Segmental Revenue

Figure 28 Sanofi Geographical Revenue

Figure 29 Vertical Pharmaceuticals LLC: Key Financials

Figure 30 Vertical Pharmaceuticals LLC: Segmental Revenue

Figure 31 Vertical Pharmaceuticals LLC: Geographical Revenue

Figure 32 DAIICHI SANKYO: Key Financials

Figure 33 DAIICHI SANKYO: Segmental Revenue

Figure 34 DAIICHI SANKYO: Geographical Revenue

Bottom of Form